business

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry - CNBC

Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs.

By:Annika Kim Constantino
Source:CNBC
Published:
Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry - CNBC
President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, Dec. 19, 2025. Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0… [+8313 chars]

Related News

Danish pension fund to sell $100 million in Treasuries, citing 'poor' U.S. government finances - CNBC
business

Danish pension fund to sell $100 million in Treasuries, citing 'poor' U.S. government finances - CNBC

AkademikerPension's move comes amid increasing tensions between Denmark and the U.S. over Greenland.

CNBC•Alex Harring
S&P 500 Sheds $750 Billion—Greenland’s Estimated Value—On Trump’s Threats, Economist Says - Forbes
business

S&P 500 Sheds $750 Billion—Greenland’s Estimated Value—On Trump’s Threats, Economist Says - Forbes

Trump has escalated his campaign for U.S. control over the Danish territory.

Forbes•Ty Roush
Canned Tuna Is Being Recalled Right Now Due to Botulism Risk - EatingWell
business

Canned Tuna Is Being Recalled Right Now Due to Botulism Risk - EatingWell

Canned tuna that was previously recalled was redistributed in nine states. These cans pose a botulism risk—here’s what to know.

Eatingwell.com•https://www.facebook.com/EatingWell/
Back to News